A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Clinical trial NCT06746883 · RECRUITING
Trial details
- NCT number
- NCT06746883
- Sponsor
- Innoviva Specialty Therapeutics
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-28
- Primary completion
- 2029-01-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.